Small caps round-up: Biome, Ceramic Fuel Cells, Chamerlin

Jul 12, 2012

Share with
friends:

Comments (0) Print this article

Technology group Biome has seen significant positive developments in the patent litigation cases currently being heard against its joint venture company, Biotec. The claims, which are being made by Italian company Novamont, are for infringement of the French and Italian designations of a number of Novamont's patents by the products that are or have been manufactured and sold by Biotec.

The court in the first instance has found in favour of Biotec and has revoked the Italian designations of Novamont's patents, with the exception of claim 12 (although this also was found not to be infringed) and EP '120. The news was described by the company as "very encouraging". A parallel case in Milan remains on going.

Fuel cell technology manufacturer Ceramic Fuel Cells has delivered strong revenue growth of around 75% higher than the previous year at £4.3m after order books doubled to 639 products. The firm believes the sales outlook for the coming financial year is strong, particularly in Germany. To ensure income grows, the company has employed more aggressive sales pricing, reduced operating costs and is pursuing several options to raise additional working capital. A large furnace will shortly be brought into production in Germany which will increase capacity to 1,500 BlueGen units each year.

Chamberlin, a specialist foundry and engineering group, has traded in line with expectations during the first three months of the financial year. The company also remains in a strong cash generative position. "The board's focus remains on increasing sales and improving Chamberlin's operational performance and we continue to make progress in these areas," the firm said at its annual general meeting.

NR

Comments (0)

Share with
friends:

Related articles

Leave a comment

This will be the name displayed with your comment.

This helps us verify comments are genuine. It will not be displayed anywhere on the site and is stored confidentially.

Please keep your comment within 1,000 characters and relevant to the main topic. We encourage healthy debate, but we don't allow insults or bad language. Anything off topic or unpleasant, we'll remove. Enjoy the conversation! Thank you.

captcha To prevent spam-related comments please enter the characters shown in the 'Captcha' box to the left.

By leaving a comment you accept our terms and conditions.


FREE - MoneyWeek's daily investment emailJohn Stepek

Our free daily email, Money Morning, is an informative and enjoyable analysis of what's going on in the markets. Written by our Editor, John Stepek, and guest contributors.
Sign up FREE to Money Morning here.

>